These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


561 related items for PubMed ID: 22094370

  • 21. Orthostatic hypotension from sympathetic denervation in Parkinson's disease.
    Goldstein DS, Holmes CS, Dendi R, Bruce SR, Li ST.
    Neurology; 2002 Apr 23; 58(8):1247-55. PubMed ID: 11971094
    [Abstract] [Full Text] [Related]

  • 22. Cardiac denervation and dysautonomia in Parkinson's disease: a review of screening techniques.
    Post KK, Singer C, Papapetropoulos S.
    Parkinsonism Relat Disord; 2008 Nov 23; 14(7):524-31. PubMed ID: 18486523
    [Abstract] [Full Text] [Related]

  • 23. Biomarkers, mechanisms, and potential prevention of catecholamine neuron loss in Parkinson disease.
    Goldstein DS.
    Adv Pharmacol; 2013 Nov 23; 68():235-72. PubMed ID: 24054148
    [Abstract] [Full Text] [Related]

  • 24. Cardiac sympathetic denervation preceding motor signs in Parkinson disease.
    Goldstein DS, Sharabi Y, Karp BI, Bentho O, Saleem A, Pacak K, Eisenhofer G.
    Clin Auton Res; 2007 Apr 23; 17(2):118-21. PubMed ID: 17334896
    [Abstract] [Full Text] [Related]

  • 25. Pure autonomic failure.
    Garland EM, Hooper WB, Robertson D.
    Handb Clin Neurol; 2013 Apr 23; 117():243-57. PubMed ID: 24095130
    [Abstract] [Full Text] [Related]

  • 26. Differential abnormalities of cerebrospinal fluid dopaminergic versus noradrenergic indices in synucleinopathies.
    Goldstein DS, Sullivan P, Holmes C, Lamotte G, Lenka A, Sharabi Y.
    J Neurochem; 2021 Jul 23; 158(2):554-568. PubMed ID: 33894018
    [Abstract] [Full Text] [Related]

  • 27. A vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson's disease.
    Goldstein DS, Sullivan P, Holmes C, Miller GW, Sharabi Y, Kopin IJ.
    J Neurochem; 2014 Oct 23; 131(2):219-28. PubMed ID: 24848581
    [Abstract] [Full Text] [Related]

  • 28. Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy.
    Goldstein DS, Holmes C, Sewell L, Park MY, Sharabi Y.
    Clin Auton Res; 2012 Feb 23; 22(1):57-61. PubMed ID: 21796351
    [Abstract] [Full Text] [Related]

  • 29. Plasma biomarkers of decreased vesicular storage distinguish Parkinson disease with orthostatic hypotension from the parkinsonian form of multiple system atrophy.
    Goldstein DS, Kopin IJ, Sharabi Y, Holmes C.
    Clin Auton Res; 2015 Feb 23; 25(1):61-7. PubMed ID: 25638582
    [Abstract] [Full Text] [Related]

  • 30. Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease.
    Sharabi Y, Goldstein DS.
    J Neurol Sci; 2011 Nov 15; 310(1-2):123-8. PubMed ID: 21762927
    [Abstract] [Full Text] [Related]

  • 31. Deficient vesicular storage: A common theme in catecholaminergic neurodegeneration.
    Goldstein DS, Holmes C, Sullivan P, Mash DC, Sidransky E, Stefani A, Kopin IJ, Sharabi Y.
    Parkinsonism Relat Disord; 2015 Sep 15; 21(9):1013-22. PubMed ID: 26255205
    [Abstract] [Full Text] [Related]

  • 32. Effect of levodopa on postural blood pressure changes in Parkinson disease: a randomized crossover study.
    Earl T, Jridi A, Thulin PC, Zorn M, McKee KE, Mitrovich K, Moretti P, Alshaikh J, Kassavetis P, Cortez MM, Lamotte G.
    Clin Auton Res; 2024 Feb 15; 34(1):117-124. PubMed ID: 38429568
    [Abstract] [Full Text] [Related]

  • 33. Neuroscience and heart-brain medicine: the year in review.
    Goldstein DS.
    Cleve Clin J Med; 2010 Jul 15; 77 Suppl 3(0 3):S34-9. PubMed ID: 20622073
    [Abstract] [Full Text] [Related]

  • 34. Dysautonomia in prodromal α-synucleinopathy: peripheral versus central autonomic degeneration.
    Dahms C, Guenther A, Schwab M, Schultze T, Nowack S, Hoyer D, Ehrhardt J, Witte OW, Mayer G, Rupprecht S.
    Eur J Neurol; 2016 May 15; 23(5):878-90. PubMed ID: 26842960
    [Abstract] [Full Text] [Related]

  • 35. Cardiac sympathetic denervation in Parkinson disease.
    Goldstein DS, Holmes C, Li ST, Bruce S, Metman LV, Cannon RO.
    Ann Intern Med; 2000 Sep 05; 133(5):338-47. PubMed ID: 10979878
    [Abstract] [Full Text] [Related]

  • 36. Do indices of baroreflex failure and peripheral noradrenergic deficiency predict the magnitude of orthostatic hypotension in Lewy body diseases?
    Lamotte G, Takahashi M, Wu T, Sullivan P, Cherup J, Holmes C, Goldstein DS.
    Clin Auton Res; 2021 Aug 05; 31(4):543-551. PubMed ID: 33710459
    [Abstract] [Full Text] [Related]

  • 37. Association between supine hypertension and orthostatic hypotension in autonomic failure.
    Goldstein DS, Pechnik S, Holmes C, Eldadah B, Sharabi Y.
    Hypertension; 2003 Aug 05; 42(2):136-42. PubMed ID: 12835329
    [Abstract] [Full Text] [Related]

  • 38. [Autonomic dysfunction in the patient with neurodegenerative disease].
    Roa-Chamorro R, Torres-Quintero L, González-Bustos P.
    Hipertens Riesgo Vasc; 2020 Aug 05; 37(3):133-136. PubMed ID: 32224047
    [Abstract] [Full Text] [Related]

  • 39. Functional effects of cardiac sympathetic denervation in neurogenic orthostatic hypotension.
    Imrich R, Eldadah BA, Bentho O, Pechnik S, Sharabi Y, Holmes C, Grossman E, Goldstein DS.
    Parkinsonism Relat Disord; 2009 Feb 05; 15(2):122-7. PubMed ID: 18514012
    [Abstract] [Full Text] [Related]

  • 40. Different phenoconversion pathways in pure autonomic failure with versus without Lewy bodies.
    Goldstein DS, Isonaka R, Lamotte G, Kaufmann H.
    Clin Auton Res; 2021 Dec 05; 31(6):677-684. PubMed ID: 34669076
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 29.